Skip to main content
. 2021 Feb 17;8(2):1482–1493. doi: 10.1002/ehf2.13236

Figure 2.

Figure 2

Effects of canagliflozin on major adverse cardiac events in participants in the CANVAS Program, stratified by baseline use of diuretic classes*. *In CANVAS Program, any diuretics were categorized as loop or non‐loop diuretics. In CANVAS trial, non‐loop diuretics were further categorized with specific drug classes. **Includes thiazide, thiazide‐like, or other diuretics.